I don't think any of those are good places to get a sense of the current scientific literature.
The Ivermectin signal has been around since 07/2020. It's a shame it took more than a year for reputable institutions to even consider touching the subject. https://c19ivermectin.com. I thought we are in a world-wide emergency crisis, where we are tapping all available resources as soon as humanly possible.
There is some hope for reputable answers from https://www.ox.ac.uk/news/2021-06-23-ivermectin-be-investiga..., yet to be completed.
The lack of large completed trials for an off patent medicine should be a black eye for the NIH.
Ivermectin is an anti-parasite drug. It is not an anti-viral. There is no theory for a mechanism of action for why it would be effective against COVID. There is some laboratory evidence that Ivermectin at very high concentrations can inhibit replication of COVID-19 and other viruses. The problem with this is that extrapolating from those concentrations to a dosing regimen means a dose of Ivermectin far, far higher than the dosage of Ivermectin given in humans.
So, without sufficient evidence, there's no compelling reason to do a large trial of Ivermectin.
> https://hcqmeta.com/#fcite_rct (Figure 7, scroll down)
> https://ivmmeta.com/#fig_fpr
Hydroxychloroquine: My personal opinion is that it's just report and publication bias.
Ivermectin: My personal opinion is that it looks more interesting, but after taking a deeper look, it's full of small studies that are not pre-registered where a fluke created an optimistic result that is not statistically significant. (I'd just drop most/all of them.)
The main difference is that Hydroxychloroquine has a few big studies with a few thousand of patients, but with Ivermectin all the RCT studies have at most a few hundred patients.
Complete thread with the original links and more discussion: https://news.ycombinator.com/item?id=27691080
It's also interesting that I pick the first RCT in the site about Ivermectin https://c19ivermectin.com/chowdhury.html , and it actually compares Ivermectin and Hydroxychloroquine. It is listed as a success in the Ivermectin site but it's not listed a failure in the Hydroxychloroquine site. Anyway, it's small and not statistically significant, so I'd not read too many conclusions from it.